By Tanya Agrawal
(Reuters) - U.S. stocks edged up on Tuesday for the second straight day as a spate of companies beat lowered earnings expectations, helping to ease fears of a disappointing quarter.
A majority of the top 10 S&P 500 sectors were up, with the health index <.SPXHC> leading the gains following Teva Pharmaceutical's
Mylan rose as much as 9.4 percent to a record high of $74.44 after Israeli drugmaker Teva made an unsolicited offer of $82 per share, in what could be the drug industry's largest takeover this year. Teva rose 2.7 percent to $65.01.
Mylan was the highest traded stock on the Nasdaq with nearly 13 million shares traded.
Nearly 75 percent of the S&P 500 components that have reported earnings so far have beat analyst expectations, topping the 70 percent average in the last four quarters. However, just 45.8 percent have beat on revenue, compared with the 58 percent average top line beat over the last year.
At 9:45 a.m. EDT the Dow Jones industrial average <.DJI> rose 12.59 points, or 0.07 percent, to 18,047.52, the S&P 500 <.SPX> gained 3.63 points, or 0.17 percent, to 2,104.03 and the Nasdaq Composite <.IXIC> was unchanged.
Dow components Verizon
The dollar is up almost 9 percent since the beginning of the year against a basket of major currencies <.DXY>. A strong dollar hurts companies with large overseas operations.
"Market is in momentum mode and is taking the path of least resistance," said Brian Fenske, head of sales trading at ITG in New York. "It's still early in the week and things could change with some major tech stock reporting later in the week but there has been the absence of a real negative factor."
IBM
Earnings expected later on Tuesday include Chipotle
Hedge fund manager David Einhorn's Greenlight Capital has taken a new stake in General Motors Co
Advancing issues outnumbered declining ones on the NYSE by 1,618 to 1,059, for a 1.53-to-1 ratio on the upside; on the Nasdaq, 1,325 issues rose and 931 fell for a 1.42-to-1 ratio favoring advancers.
(Reporting by Tanya Agrawal; Editing by Savio D'Souza)
Relacionados
- La Fundación Puigvert pide incluir la vacuna del papiloma también para hombres
- La Fundación CajaSur "ha mejorado la vida" de 750.000 personas en los últimos cuatro años
- La Fundación Puigvert pide incluir la vacuna del papiloma también para hombres
- UPyD pide la supresión de la Fundación Villalar por considerarla "innecesaria e inoportuna" para la Comunidad
- Gobierno vasco y Fundación Bagabiltza ponen en marcha un servicio de formación para adultos en Arratia